Our Story
OneTest, is the first test of its kind powered by machine learning to combine the results of a cancer biomarker blood test and personal health data to calculate a probability score for multiple types of cancer including lung, liver, pancreatic, prostate, and more.
Our goal at 20/20 Genesystems is to provide advanced cancer screening and early detection We have been working to reduce cancer mortality around the world through early detection, beginning with our first lung cancer screening test, Paula’s Test.
OneTest is currently being used by multiple fire departments and health-conscious individuals in the United States, but is also available internationally in Japan, Austria, Jordan, and Taiwan.